Richard Pzena Abb Vie Inc. Transaction History

Pzena Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $667,452 - $743,580	-6,344 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $11,355 - $12,500	111 Added 1.78%	6,344 $687,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $11,107 - $14,996	138 Added 2.26%	6,233 $668,000
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $97,078 - $113,937	-1,130 Reduced 15.64%	6,095 $534,000
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $60,456 - $80,900	-824 Reduced 10.24%	7,225 $709,000
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $314,115 - $476,237	4,870 Added 153.19%	8,049 $613,000
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $200,213 - $240,713	3,179 New	3,179 $241,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.